BusinessAdmera Health Expands Asian Footprint with Three Strategic PartnershipsBy Nasdaq OMXSep 12, 2017, 3:05 PM UTC
BusinessColumbia University Medical Center’s Center for Biomedical Informatics Collaborates with Admera Health in a Clinical Study, Evaluating Pharmacogenetics in Psychiatric MedicationsBy Nasdaq OMXJul 25, 2017, 11:00 PM UTC
BusinessUniversity of Rochester School of Medicine and Dentistry Collaborate with Admera Health in a Clinical Study, Evaluating Pharmacogenomics in Acute Surgical Pain ManagementBy Nasdaq OMXMay 9, 2017, 1:13 PM UTC
BusinessAdmera Health Reaches Yet Another Significant Milestone, by Achieving New CLEP Approval for PGxOne™ Plus, a 50 Gene Pharmacogenomics TestBy Nasdaq OMXMar 16, 2017, 2:31 PM UTC
BusinessAdmera Health Reaches Significant Major Milestone in Achieving New York Department of CLEP Approval for PGxOne™ Plus, a 25 Gene Pharmacogenomics TestBy Nasdaq OMXNov 1, 2016, 1:13 PM UTC
BusinessAdmera Health Expands its Next Generations Sequencing Based Pharmacogenomics Test with Update to PGxOne™ PlusBy Nasdaq OMXSep 21, 2016, 1:00 PM UTC
